Oversense Sendromları
Özet
Referanslar
Prystowsky EN, Nisam S. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 2000;86:1214-5, A5.
Chang PC, Chen WT, Wo HT, et al. Long-term survival of multicenter automatic defibrillator implantation trial (MADIT) II-eligible patients in Taiwan. Acta Cardiol Sin 2014;30:229-35.
Dorwarth U, Frey B, Dugas M, et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
Brignole M. Are complications of implantable defibrillators under- estimated and benefits over-estimated? Europace 2009;11: 1129-33.
John RM, Stevenson WG. Ventricular arrhythmias in patients with implanted cardioverter defibrillators. Trends Cardiovasc Med 2012;22:169-73.
Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
Poole J, Johnson G, Hellkamp A, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med2008;359:1009-17.
Chen RH, Chen KP, Wang FZ, et al. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chin Med J (Engl) 2006;119:557-63.
Tzeis S, Andrikopoulos G, Rassias I, Theodorakis G. Tachycardia induction due to inappropriate implantable cardioverter defibrillator therapy: what is the mechanism? Hellenic J Cardiol2010;51:558-62.
Israel CW, Grönefeld G, Iscolo N, et al. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function. Pacing Clin Electrophysiol 2001;24:183-90.
Gunderson BD, Swerdlow CD, Wilcox JM, et al. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture. Heart Rhythm 2010; 7:626-33.
Duru F, Bauersfeld U, Candinas R. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of theelectrogram width criterion. Europace 2001;3:80-4.
Poole J, Johnson G, Hellkamp A, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996;7:542-58.
Lambiase PD, Barr C, Theuns DA, et al; EFFORTLESS Investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35:1657–1665.
Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: The START study. J Cardiovasc Electrophysiol 2012;23:359–366.
Israel CW. How to avoid inappropriate therapy. Curr Opin Cardiol2008;23:65-71.
Swerdlow CD, Asirvatham SJ, Ellenbogen KA, Friedman PA. Troubleshootingimplanted cardioverter defibrillator sensing problems I. Circ Arrhythm Electrophysiol 2014;7:1237-61.
Gillberg J. Detection of cardiac tachyarrhythmias in implantable devices. J Electrocardiol 2007;40:S123-8.
Lopera G, Curtis AB. Pacemaker Troubleshooting. In : Curtis AB. Fundamentals of cardiac pacing. Sudbury: Jones and Bartlett Publishers; 2010. P.171-96
Larbig R, Bettin M, Motloch LJ, Fischer A, Bode N, Frommeyer G, et al.Management of inappropriate shocks/T-wave-oversensing in SICD ®-patients. Herzschrittmacherther Elektrophysiol. 2018;29(1): 122–6.
Punjabi AH, Dermovsesian A, Karnik AA. T-wave oversensing is more dependent on ICD sensitivity algorithm than lead sensing configuration. J Electrocardiol. 2018;51(4):734–7. https://doi.org/10. 1016/j.jelectrocard.2018.05.010.
Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm 2014;11:426-34.
Pacing&Defibrilasyon .Spontaneous T-wave oversensing. [Online] (Accessed: 1 May2023)https://www.cardiocases.com/en/pacingdefibrillation/clinical-situation/icd
Morschhäuser D, Fischer W, Jakob M (2019) Praxis der Herzschrittmacher-Nachsorge: Grundlagen, Funktionen, Kontrolle, Optimierung, Troubleshootinghttps://doi.org/10.1007/978-3-662-57828-5
Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H. Implantable cardioverterdefibrillators in patients with hypertrophic cardiomyopathy—sdilemmas and difficulties. Kardiol Pol. 2005;63:391–397; discussion 398.
Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U, Borggrefe M. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol. 2003;14:1273–1277.
Sun Y, Zhang P, Li X, Guo J. Inappropriate ICD discharge due to T-wave oversensing in a patient with short QT syndrome. Pacing Clin Electrophysiol. 2010;33:113–116. doi:10.1111/j.1540-8159.2009.02538.x.
Cohen MI, Anagnostopoulos PV, Papez A. An unusual resolution of T-wave oversensing in an implantable cardioverter defibrillator in a child with long QT syndrome. J Interv Card Electrophysiol. 2009;25:235–238. doi:10.1007/s10840-008-9353-8.
Perry GY, Kosar EM. Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases. Pacing Clin Electrophysiol. 1996;19:863–867.
Koul AK, Keller S, Clancy JF, Lampert R, Batsford WP, Rosenfeld LE. Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks. Pacing Clin Electrophysiol. 2004;27:681–683. doi:10.1111/j.1540-8159.2004.00509.x.
Rasania SP, Mountantonakis S, Patel VV. Inappropriate ICD shocks caused by T-wave oversensing due to acute alcohol intoxication. Pacing Clin Electrophysiol. 2012;35:e267–e271.doi:10.1111/j.1540-8159.2012.03348.x.
Assadian Rad M, Emkanjoo Z, Moladoust H. Hyperglycemia-Induced T-Wave Oversensing as a Cause of Cardiac Resynchronization Therapy (CRT) Failure. J Tehran Heart Cent. 2012;7:30–32.
Topf A.,Motloch L, Kraus J et al. Exercise-related T-wave oversensing: an underestimated cause of reduced exercise capacity in a pacemaker-dependent patient—a case report and review of the literatüre. Journal of Interventional Cardiac Electrophysiology (2020) 59:67–70https://doi.org/10.1007/s10840-019-00698-6
Zorzi A, ElMaghawry M, Rigato I, Cardoso Bianchini F, Crespi Ponta G, Michieli P, Migliore F, Perazzolo Marra M, Bauce B, Basso C, Schiavon M, Thiene G, Iliceto S, Corrado D. Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2013;112:411-5.
Porres JM, Brugada J, Marco P, García F, Azcarate B. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome. Pacing Clin Electrophysiol. 2004;27:1563–1565. doi:10.1111/j.1540-8159.2004.00677.x.
Alizadeh A, Haghjoo M, Arya A, Fazelifar AF, Alasti M, Bagherzadeh AA, Sadr-Ameli MA. Inappropriate ICD discharge due to T-wave oversensing in a patient with the Brugada syndrome. J Interv Card Electrophysiol. 2006;15:65–68. doi:10.1007/s10840-006-7623-x.
Schuller JL, Lowery CM, Weinberger HD, Sauer WH. Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis. J Interv Card Electrophysiol. 2011;30:81–85. doi:10.1007/s10840-009-9424-5.
Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DA, Burke MC, Weiss R, Russo AM, Kääb S, Knight BP. Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. Heart Rhythm 2016;13:1066-74.
Antoine Kossaify .Sensing and Detection Functions in Implantable Cardioverter Defibrillators: The Good, the Bad and the Ugly. Acta Cardiol Sin 2020;36:308-317. doi: 10.6515/ACS.202007_36(4).20191201A
Silver JS, Gray ME, John RM. Strategy to eliminate inappropriate shocks secondary to T-wave oversensing in a biventricular ICD. Pacing Clin Electrophysiol. 2009;32:134-6.
Sweeney MO, Ellison KE, Shea JB, Newell JB. Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001;12:402–410.
Kowalski M, Ellenbogen KA, Wood MA, Friedman PL. Implantable cardiac defibrillator lead failure or myopotential oversensing? An approach to the diagnosis of noise on lead electrograms. Europace. 2008;10:914–917. doi:10.1093/europace/eun167.
Nagamoto Y, Shiomi T,Matsuura K et al. Ventricular pacing inhibition by oversensing due to diaphragmatic myopotential during deep inspiration. Case report. Journal of Cardiology Cases 8 (2013) e81–e84.
Santos KR, Adragão P, Cavaco D, Morgado FB, Candeias R, Lima S, Silva JA. Diaphragmatic myopotential oversensing in pacemaker-dependent patients with CRT-D devices. Europace.2008;10:1381–1386. doi:10.1093/ europace/eun241.
Swerdlow CD, Ellenbogen KA. Implantable cardioverter-defibrillator leads: design, diagnostics, and management. Circulation. 2013;128:2062– 71, 1. doi:10.1161/CIRCULATIONAHA.113.003920.
Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation. 2013;128:2799–2809. doi:10.1161/ CIRCULATIONAHA.113.005697.
Tandogan I, Temizhan A,Yetkin E, et al. The effects of mobile hones on pacemaker function. Int J Cardiol. 2005;103:51-8
Mc Ivor ME, Reddinger J, Floden E, et al. Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS). Pacing Clin Electrophysiol. 1998;21:1847-61
Apfelbaum J, Connis T, Nickinovich D, Rozner M, Zaidan J. Practice advisory for the perioperative management of patients with cardiacimplantable devices: pacemaker and implantable cardioverter-defibrillators. Anesthesiology. 2011;114:247–261.
Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantabledefibrillators, pacemakers and arrhythmia monitors: facilities and patientmanagement this document was developed as a joint project withthe American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011;8:1114–1154. doi:10.1016/j. hrthm.2010.12.023.
Sklyar E, Bella J. Evaluation and Monitoring of Patients With Cardiovascular Implantable Electronic Devices Undergoing Noncardiac Surgery. Health Services Insights Volume 10: 1–5 © The Author(s) 2017 Reprints and permissions:sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178632916686073
Foo D, Walker BD, Kuchar DL, et al. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol. 2009;32:879–887. doi:10.1111/j.1540-8159.2009.02403.x.
Thomas IC, Cork DP, Levy A, et al..ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation. Pacing Clin Electrophysiol. 2014;37:464– 472. doi:10.1111/pace.12290.
Biviano A, Mancini D, Naka Y, et al. Overcoming electromagnetic interference by LVADs on ICD function by shielding the ICD programmer wand and extension cable. Pacing Clin Electrophysiol. 2009;32:945–948. doi:10.1111/j.1540-8159.2009.02419.x
Ozes A, DeNofrio D, Pham DT, et al. Inappropriate implantable cardioverter-defibrillator therapy due to electromagnetic interference in patient with a HeartWare HVAD left ventricular assist device. Heart Rhythm. 2011;8:778–780. doi:10.1016/j.hrthm.2010.11.026.
Labedi MR, Alharethi R, Kfoury AG, et al. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device. ASAIO J. 2013;59:136–139. doi:10.1097/MAT.0b013e318285fe93
.Boudghène-Stambouli F, Boulé S, Goéminne C, et al. Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2014;39:177–184. doi:10.1007/ s10840-013-9854-y
Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011;155:415–424. doi:10.7326/0003-4819-155-7-201110040-00004
Kleemann T, Becker T, Doenges K,et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–2480. doi:10.1161/ CIRCULATIONAHA.106.663807.
Cheung JW, Iwai S, Lerman BB, et al. Shock-induced ventricular oversensing due to seal plug damage: a potential mechanism of inappropriate device therapies in implantable cardioverter-defibrillators. Heart Rhythm. 2005;2:1371–1375. doi:10.1016/j.hrthm.2005.09.005.
Tandogan I. Kalıcı Kalp Pilinin Programlanması Ve Fonksiyon Bozuklukları. In: Kozan O(ed.) Temel Kardiyoloji. Ankara: Güneş Tıp Kitabevleri; 2011. p. 1283-1293
Kusumoto FM,Goldsclager NF. Cardiac Pacing for the Clinician. Second edition, New York, Springer; 2008
Love CJ. Cardiac Pacemakers and Defibrillators. Texas: Landes Bioscince. 2006
Barold SS, Stroobandt RX,Sinnaeve AS. Cardiac pacemakers. Step by step. Massachusetts:Blackwell Publishing. 2004
Referanslar
Prystowsky EN, Nisam S. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 2000;86:1214-5, A5.
Chang PC, Chen WT, Wo HT, et al. Long-term survival of multicenter automatic defibrillator implantation trial (MADIT) II-eligible patients in Taiwan. Acta Cardiol Sin 2014;30:229-35.
Dorwarth U, Frey B, Dugas M, et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
Brignole M. Are complications of implantable defibrillators under- estimated and benefits over-estimated? Europace 2009;11: 1129-33.
John RM, Stevenson WG. Ventricular arrhythmias in patients with implanted cardioverter defibrillators. Trends Cardiovasc Med 2012;22:169-73.
Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
Poole J, Johnson G, Hellkamp A, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med2008;359:1009-17.
Chen RH, Chen KP, Wang FZ, et al. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chin Med J (Engl) 2006;119:557-63.
Tzeis S, Andrikopoulos G, Rassias I, Theodorakis G. Tachycardia induction due to inappropriate implantable cardioverter defibrillator therapy: what is the mechanism? Hellenic J Cardiol2010;51:558-62.
Israel CW, Grönefeld G, Iscolo N, et al. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function. Pacing Clin Electrophysiol 2001;24:183-90.
Gunderson BD, Swerdlow CD, Wilcox JM, et al. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture. Heart Rhythm 2010; 7:626-33.
Duru F, Bauersfeld U, Candinas R. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of theelectrogram width criterion. Europace 2001;3:80-4.
Poole J, Johnson G, Hellkamp A, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996;7:542-58.
Lambiase PD, Barr C, Theuns DA, et al; EFFORTLESS Investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35:1657–1665.
Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: The START study. J Cardiovasc Electrophysiol 2012;23:359–366.
Israel CW. How to avoid inappropriate therapy. Curr Opin Cardiol2008;23:65-71.
Swerdlow CD, Asirvatham SJ, Ellenbogen KA, Friedman PA. Troubleshootingimplanted cardioverter defibrillator sensing problems I. Circ Arrhythm Electrophysiol 2014;7:1237-61.
Gillberg J. Detection of cardiac tachyarrhythmias in implantable devices. J Electrocardiol 2007;40:S123-8.
Lopera G, Curtis AB. Pacemaker Troubleshooting. In : Curtis AB. Fundamentals of cardiac pacing. Sudbury: Jones and Bartlett Publishers; 2010. P.171-96
Larbig R, Bettin M, Motloch LJ, Fischer A, Bode N, Frommeyer G, et al.Management of inappropriate shocks/T-wave-oversensing in SICD ®-patients. Herzschrittmacherther Elektrophysiol. 2018;29(1): 122–6.
Punjabi AH, Dermovsesian A, Karnik AA. T-wave oversensing is more dependent on ICD sensitivity algorithm than lead sensing configuration. J Electrocardiol. 2018;51(4):734–7. https://doi.org/10. 1016/j.jelectrocard.2018.05.010.
Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm 2014;11:426-34.
Pacing&Defibrilasyon .Spontaneous T-wave oversensing. [Online] (Accessed: 1 May2023)https://www.cardiocases.com/en/pacingdefibrillation/clinical-situation/icd
Morschhäuser D, Fischer W, Jakob M (2019) Praxis der Herzschrittmacher-Nachsorge: Grundlagen, Funktionen, Kontrolle, Optimierung, Troubleshootinghttps://doi.org/10.1007/978-3-662-57828-5
Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H. Implantable cardioverterdefibrillators in patients with hypertrophic cardiomyopathy—sdilemmas and difficulties. Kardiol Pol. 2005;63:391–397; discussion 398.
Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U, Borggrefe M. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol. 2003;14:1273–1277.
Sun Y, Zhang P, Li X, Guo J. Inappropriate ICD discharge due to T-wave oversensing in a patient with short QT syndrome. Pacing Clin Electrophysiol. 2010;33:113–116. doi:10.1111/j.1540-8159.2009.02538.x.
Cohen MI, Anagnostopoulos PV, Papez A. An unusual resolution of T-wave oversensing in an implantable cardioverter defibrillator in a child with long QT syndrome. J Interv Card Electrophysiol. 2009;25:235–238. doi:10.1007/s10840-008-9353-8.
Perry GY, Kosar EM. Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases. Pacing Clin Electrophysiol. 1996;19:863–867.
Koul AK, Keller S, Clancy JF, Lampert R, Batsford WP, Rosenfeld LE. Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks. Pacing Clin Electrophysiol. 2004;27:681–683. doi:10.1111/j.1540-8159.2004.00509.x.
Rasania SP, Mountantonakis S, Patel VV. Inappropriate ICD shocks caused by T-wave oversensing due to acute alcohol intoxication. Pacing Clin Electrophysiol. 2012;35:e267–e271.doi:10.1111/j.1540-8159.2012.03348.x.
Assadian Rad M, Emkanjoo Z, Moladoust H. Hyperglycemia-Induced T-Wave Oversensing as a Cause of Cardiac Resynchronization Therapy (CRT) Failure. J Tehran Heart Cent. 2012;7:30–32.
Topf A.,Motloch L, Kraus J et al. Exercise-related T-wave oversensing: an underestimated cause of reduced exercise capacity in a pacemaker-dependent patient—a case report and review of the literatüre. Journal of Interventional Cardiac Electrophysiology (2020) 59:67–70https://doi.org/10.1007/s10840-019-00698-6
Zorzi A, ElMaghawry M, Rigato I, Cardoso Bianchini F, Crespi Ponta G, Michieli P, Migliore F, Perazzolo Marra M, Bauce B, Basso C, Schiavon M, Thiene G, Iliceto S, Corrado D. Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2013;112:411-5.
Porres JM, Brugada J, Marco P, García F, Azcarate B. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome. Pacing Clin Electrophysiol. 2004;27:1563–1565. doi:10.1111/j.1540-8159.2004.00677.x.
Alizadeh A, Haghjoo M, Arya A, Fazelifar AF, Alasti M, Bagherzadeh AA, Sadr-Ameli MA. Inappropriate ICD discharge due to T-wave oversensing in a patient with the Brugada syndrome. J Interv Card Electrophysiol. 2006;15:65–68. doi:10.1007/s10840-006-7623-x.
Schuller JL, Lowery CM, Weinberger HD, Sauer WH. Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis. J Interv Card Electrophysiol. 2011;30:81–85. doi:10.1007/s10840-009-9424-5.
Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DA, Burke MC, Weiss R, Russo AM, Kääb S, Knight BP. Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. Heart Rhythm 2016;13:1066-74.
Antoine Kossaify .Sensing and Detection Functions in Implantable Cardioverter Defibrillators: The Good, the Bad and the Ugly. Acta Cardiol Sin 2020;36:308-317. doi: 10.6515/ACS.202007_36(4).20191201A
Silver JS, Gray ME, John RM. Strategy to eliminate inappropriate shocks secondary to T-wave oversensing in a biventricular ICD. Pacing Clin Electrophysiol. 2009;32:134-6.
Sweeney MO, Ellison KE, Shea JB, Newell JB. Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001;12:402–410.
Kowalski M, Ellenbogen KA, Wood MA, Friedman PL. Implantable cardiac defibrillator lead failure or myopotential oversensing? An approach to the diagnosis of noise on lead electrograms. Europace. 2008;10:914–917. doi:10.1093/europace/eun167.
Nagamoto Y, Shiomi T,Matsuura K et al. Ventricular pacing inhibition by oversensing due to diaphragmatic myopotential during deep inspiration. Case report. Journal of Cardiology Cases 8 (2013) e81–e84.
Santos KR, Adragão P, Cavaco D, Morgado FB, Candeias R, Lima S, Silva JA. Diaphragmatic myopotential oversensing in pacemaker-dependent patients with CRT-D devices. Europace.2008;10:1381–1386. doi:10.1093/ europace/eun241.
Swerdlow CD, Ellenbogen KA. Implantable cardioverter-defibrillator leads: design, diagnostics, and management. Circulation. 2013;128:2062– 71, 1. doi:10.1161/CIRCULATIONAHA.113.003920.
Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation. 2013;128:2799–2809. doi:10.1161/ CIRCULATIONAHA.113.005697.
Tandogan I, Temizhan A,Yetkin E, et al. The effects of mobile hones on pacemaker function. Int J Cardiol. 2005;103:51-8
Mc Ivor ME, Reddinger J, Floden E, et al. Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS). Pacing Clin Electrophysiol. 1998;21:1847-61
Apfelbaum J, Connis T, Nickinovich D, Rozner M, Zaidan J. Practice advisory for the perioperative management of patients with cardiacimplantable devices: pacemaker and implantable cardioverter-defibrillators. Anesthesiology. 2011;114:247–261.
Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantabledefibrillators, pacemakers and arrhythmia monitors: facilities and patientmanagement this document was developed as a joint project withthe American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011;8:1114–1154. doi:10.1016/j. hrthm.2010.12.023.
Sklyar E, Bella J. Evaluation and Monitoring of Patients With Cardiovascular Implantable Electronic Devices Undergoing Noncardiac Surgery. Health Services Insights Volume 10: 1–5 © The Author(s) 2017 Reprints and permissions:sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178632916686073
Foo D, Walker BD, Kuchar DL, et al. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol. 2009;32:879–887. doi:10.1111/j.1540-8159.2009.02403.x.
Thomas IC, Cork DP, Levy A, et al..ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation. Pacing Clin Electrophysiol. 2014;37:464– 472. doi:10.1111/pace.12290.
Biviano A, Mancini D, Naka Y, et al. Overcoming electromagnetic interference by LVADs on ICD function by shielding the ICD programmer wand and extension cable. Pacing Clin Electrophysiol. 2009;32:945–948. doi:10.1111/j.1540-8159.2009.02419.x
Ozes A, DeNofrio D, Pham DT, et al. Inappropriate implantable cardioverter-defibrillator therapy due to electromagnetic interference in patient with a HeartWare HVAD left ventricular assist device. Heart Rhythm. 2011;8:778–780. doi:10.1016/j.hrthm.2010.11.026.
Labedi MR, Alharethi R, Kfoury AG, et al. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device. ASAIO J. 2013;59:136–139. doi:10.1097/MAT.0b013e318285fe93
.Boudghène-Stambouli F, Boulé S, Goéminne C, et al. Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2014;39:177–184. doi:10.1007/ s10840-013-9854-y
Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011;155:415–424. doi:10.7326/0003-4819-155-7-201110040-00004
Kleemann T, Becker T, Doenges K,et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–2480. doi:10.1161/ CIRCULATIONAHA.106.663807.
Cheung JW, Iwai S, Lerman BB, et al. Shock-induced ventricular oversensing due to seal plug damage: a potential mechanism of inappropriate device therapies in implantable cardioverter-defibrillators. Heart Rhythm. 2005;2:1371–1375. doi:10.1016/j.hrthm.2005.09.005.
Tandogan I. Kalıcı Kalp Pilinin Programlanması Ve Fonksiyon Bozuklukları. In: Kozan O(ed.) Temel Kardiyoloji. Ankara: Güneş Tıp Kitabevleri; 2011. p. 1283-1293
Kusumoto FM,Goldsclager NF. Cardiac Pacing for the Clinician. Second edition, New York, Springer; 2008
Love CJ. Cardiac Pacemakers and Defibrillators. Texas: Landes Bioscince. 2006
Barold SS, Stroobandt RX,Sinnaeve AS. Cardiac pacemakers. Step by step. Massachusetts:Blackwell Publishing. 2004
